Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Supplementary material for the financial results for the year ended March 31, 2025
TOWA PHARMA, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 10 yen
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)